SLC6A2 and Anxiety: For assessment of clinical anxiety state in the independent test cohort, SLC6A2, increased in expression in high anxiety in our work, had an AUC of 63% (p = 0.02) across all subjects, and 76% (p = 0.0005) in females, surviving Bonferroni correction for all 95 biomarkers tested.